Course Description

Clinical Data for Reimbursement

Course Description:

This course provides a strategic and detailed overview of how choosing the right clinical data can accelerate time to market. It illustrates how investing in clinical trials and the right clinical development plans early on can bridge the gap between development and marketing, increase returns on investment, and create better availability for patients.

Watch the Course Trailer:

 

 


Learning Objectives:

Upon successfully completing this course, learners will be able to:

  • Demonstrate how choosing the right clinical trials is an investment worthy of time and money
  • Explain how trying to save money on clinical trials actually prolongs the time to market
  • Illustrate how serious clinical evidence convinces buyers
  • Recognize that shortcuts do not pay off in the long run

Who Should Enroll:

Clinical, regulatory, reimbursement, and marketing managers, CEOs, and board of directors members (of start-ups) are all encouraged to enroll in this course.


Prerequisite Knowledge/Requirements:

The following material is required:

  • Definition of prospective vs. retrospective, controlled vs. uncontrolled, randomized vs. non-randomized, and blinded vs. non-blinded trials
  • Designing a Strategic Clinical Investigation Plan (series; IDs N140–N142) Health Economic Evaluation of Medical Technologies (ID 115)

Subject Matter Expert:
Lucio Fumi

Duration:
57 min

Release date:
02/17/2011

Related resources:
Yes

Case studies:
No

Price:
Basic Account: € 233.00
Premium Account: € 175.00

Change Currency:
€ EUR$ USD¥ JPY
Add to cart